Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
SIBN	SI-BONE INC	$661.72M	-12.90%	-9.40%	-9.12%	-9.10%	0.36	7.97	79.60%	-11.20%	-9.80%
OGN	ORGANON & CO	$1.89B	75.50%	3.80%	11.19%	9.50%	13.96	1.75	55.00%	8.00%	19.31%
HLN	HALEON PLC	$51.01B	8.80%	4.20%	7.64%	20.40%	1.12	0.98	60.70%	12.80%	19.40%
FLGT	FULGENT GENETICS INC	$729.53M	-3.80%	-3.60%	-4.17%	-5.30%	0.08	7.01	41.20%	-13.60%	-15.09%
NHC	NATIONAL HEALTHCARE CORP	$2.56B	10.00%	6.50%	11.01%	12.20%	0.49	1.75	100.00%	6.70%	9.47%
IMCR	IMMUNOCORE HOLDINGS PLC	$1.64B	-7.70%	-2.80%	-1.28%	-1.40%	1.78	6.00	99.30%	-7.70%	-3.15%
ZBH	ZIMMER BIOMET HOLDINGS INC	$19.25B	6.40%	3.60%	6.18%	10.60%	0.84	2.43	71.40%	10.10%	16.26%
BMRN	BIOMARIN PHARMACEUTICAL INC	$11.52B	8.80%	7.10%	10.12%	12.20%	0.26	4.83	81.30%	16.80%	22.30%
VRCA	VERRICA PHARMACEUTICALS INC	$52.29M	N/A	-59.00%	-143.79%	-62.50%	-3.40	1.26	91.40%	-84.40%	-55.91%
VEEV	VEEVA SYSTEMS INC	$29.07B	13.40%	11.00%	15.69%	25.10%	0.15	7.53	75.70%	27.90%	36.43%
PDEX	PRO DEX INC	$127.95M	29.30%	18.00%	32.20%	26.90%	0.50	4.03	28.30%	15.70%	22.35%
IDYA	IDEAYA BIOSCIENCES INC	$2.70B	-11.10%	-10.30%	-10.82%	-12.40%	0.08	11.34	100.00%	-52.00%	-51.99%
NRC	NATIONAL RESEARCH CORP	$272.57M	67.80%	12.00%	28.38%	27.80%	8.48	0.53	62.10%	11.80%	19.82%
LQDA	LIQUIDIA CORP	$2.94B	-296.80%	-49.20%	-57.91%	-60.30%	11.52	2.20	89.10%	-176.00%	-144.78%
WAT	WATERS CORP	$19.14B	31.30%	13.90%	23.31%	28.30%	1.09	1.53	59.00%	20.90%	27.11%
BWAY	BRAINSWAY LTD	$471.80M	9.50%	6.00%	10.36%	49.00%	0.61	3.19	74.90%	12.70%	18.37%
AMGN	AMGEN INC	$201.27B	96.70%	8.60%	18.02%	16.50%	9.46	1.14	67.20%	21.00%	31.92%
AZTA	AZENTA INC	$1.32B	-3.40%	-2.80%	-4.97%	-11.70%	0.21	2.92	44.60%	-9.70%	-15.11%
BDTX	BLACK DIAMOND THERAPEUTICS INC	$127.05M	17.80%	13.80%	15.12%	20.30%	0.25	8.94	100.00%	30.70%	30.71%
ZYME	ZYMEWORKS INC	$1.73B	-19.20%	-15.00%	-15.78%	-19.20%	0.24	6.94	100.00%	-47.20%	-41.69%
PARK	PARK DENTAL PARTNERS INC	N/A	N/A	N/A	N/A	N/A	406.32	0.52	N/A	N/A	N/A
PHG	KONINKLIJKE PHILIPS NV	$28.88B	-5.80%	-2.40%	3.11%	4.90%	1.41	1.23	43.10%	-3.90%	3.60%
CTKB	CYTEK BIOSCIENCES INC	$537.03M	-3.30%	-2.60%	-2.32%	-3.20%	0.31	5.17	53.50%	-6.50%	-4.95%
IRTC	IRHYTHM HOLDINGS INC	$4.78B	-51.10%	-5.40%	-4.44%	-3.10%	7.17	4.63	70.40%	-7.30%	-5.36%
CAI	CARIS LIFE SCIENCES INC	$5.87B	N/A	N/A	N/A	N/A	1.06	9.93	N/A	N/A	N/A
ISRG	INTUITIVE SURGICAL INC	$175.20B	16.40%	14.40%	17.83%	23.80%	0.14	4.88	66.00%	28.40%	32.70%
JYNT	JOINT CORP	$132.61M	9.20%	2.60%	4.28%	17.30%	2.06	1.83	-575.50%	113.00%	90.88%
CERT	CERTARA INC	$1.04B	1.00%	0.70%	2.31%	10.20%	0.44	2.09	61.40%	2.60%	7.78%
ASND	ASCENDIS PHARMA A	$13.71B	N/A	-19.80%	-2.56%	-0.90%	-9.00	1.04	86.80%	-31.70%	-0.83%
FTRE	FORTREA HOLDINGS INC	$896.28M	-119.70%	-33.10%	-50.31%	-67.10%	3.72	1.00	18.60%	-36.80%	-33.32%
SLP	SIMULATIONS PLUS INC	$243.77M	-45.50%	-42.40%	-53.87%	-275.60%	0.08	5.62	59.60%	-81.70%	-87.29%
DOMH	DOMINARI HOLDINGS INC	$54.28M	116.20%	102.20%	51.12%	114.70%	0.06	27.54	100.00%	110.90%	110.86%
OWLT	OWLET INC	$297.04M	N/A	-70.90%	-295.52%	-471.50%	-2.10	1.14	52.10%	-42.60%	-35.37%
LXRX	LEXICON PHARMACEUTICALS INC	$479.69M	-52.90%	-26.70%	-31.71%	-33.80%	0.71	5.64	99.40%	-96.80%	-82.43%
AMPH	AMPHASTAR PHARMACEUTICALS INC	$1.31B	14.80%	6.90%	11.02%	12.20%	1.15	3.12	49.40%	15.40%	22.25%
WRBY	WARBY PARKER INC	$2.68B	0.20%	0.10%	-1.37%	-1.50%	0.91	2.61	54.40%	0.10%	-0.93%
NEO	NEOGENOMICS INC	$1.49B	-12.60%	-7.50%	-8.38%	-14.90%	0.63	4.26	43.20%	-14.90%	-14.64%
BSX	BOSTON SCIENTIFIC CORP	$113.21B	12.60%	6.90%	9.78%	16.90%	0.79	1.62	69.00%	14.40%	18.63%
ALC	ALCON INC	$39.65B	4.80%	3.40%	5.06%	10.30%	0.43	2.12	55.10%	10.30%	14.18%
TFX	TELEFLEX INC	$4.68B	-8.00%	-4.40%	-2.83%	-5.60%	1.06	2.57	53.70%	-10.30%	-6.30%
CNMD	CONMED CORP	$1.31B	4.70%	2.00%	5.08%	7.10%	1.25	2.14	54.60%	3.40%	7.43%
MYGN	MYRIAD GENETICS INC	$419.46M	-73.90%	-46.60%	-72.14%	-111.80%	0.95	2.33	70.40%	-48.50%	-50.71%
ESPR	ESPERION THERAPEUTICS INC	$848.68M	N/A	-30.70%	-550.25%	-5.10%	-1.81	1.00	58.20%	-34.80%	-9.03%
BLLN	BILLIONTOONE INC	$4.26B	N/A	N/A	N/A	N/A	-0.62	6.17	N/A	N/A	N/A
UTMD	UTAH MEDICAL PRODUCTS INC	$209.39M	9.90%	9.50%	12.29%	74.40%	0.03	32.06	57.10%	30.10%	37.84%
RVTY	REVVITY INC	$10.78B	3.10%	1.90%	3.38%	7.80%	0.65	1.75	55.30%	8.40%	13.10%
CRMD	CORMEDIX INC	$568.07M	81.80%	51.10%	17.50%	93.70%	1.01	1.94	92.60%	75.80%	50.40%
CYH	COMMUNITY HEALTH SYSTEMS INC	$476.51M	-18.90%	2.40%	11.52%	6.60%	-9.45	1.47	84.80%	2.60%	10.08%
CLLS	CELLECTIS SA	$280.62M	-31.80%	-9.80%	-4.50%	-4.00%	2.41	1.49	100.00%	-42.80%	-10.61%
KRYS	KRYSTAL BIOTECH INC	$8.41B	18.70%	17.10%	15.39%	26.00%	0.09	9.95	94.10%	52.60%	48.69%
CNC	CENTENE CORP	$20.28B	-27.70%	-8.00%	-15.10%	-21.70%	2.84	1.10	7.10%	-3.40%	-3.10%
EVAX	EVAXION A	$19.96M	-320.20%	-63.60%	-59.92%	-74.40%	2.61	3.42	100.00%	-377.00%	-323.11%
CPIX	CUMBERLAND PHARMACEUTICALS INC	$57.58M	-12.60%	-4.80%	-6.64%	-12.10%	1.54	1.23	84.50%	-8.10%	-6.69%
ACRS	ACLARIS THERAPEUTICS INC	$353.21M	-102.80%	-72.40%	-94.51%	-99.10%	0.46	3.93	4.00%	-900.00%	-900.01%
ESTA	ESTABLISHMENT LABS HOLDINGS INC	$2.16B	-253.80%	-24.60%	-21.76%	-14.10%	19.71	3.33	68.70%	-43.50%	-30.42%
SGHT	SIGHT SCIENCES INC	$282.86M	-61.60%	-36.10%	-39.32%	-84.10%	0.81	9.60	86.00%	-60.60%	-53.98%
YCBD	CBDMD INC	$8.14M	-64.60%	-34.50%	-26.22%	-97.00%	0.31	2.94	60.60%	-19.50%	-12.37%
CVS	CVS HEALTH CORP	$99.49B	2.30%	0.70%	3.21%	4.40%	2.37	0.84	13.80%	0.40%	1.32%
AXSM	AXSOME THERAPEUTICS INC	$9.24B	-357.20%	-37.10%	-72.12%	-135.20%	8.08	1.57	91.90%	-40.90%	-39.70%
KROS	KEROS THERAPEUTICS INC	$503.30M	9.50%	8.90%	9.90%	160.40%	0.06	29.86	100.00%	26.10%	28.84%
NBTX	NANOBIOTIX SA	$1.28B	N/A	-78.30%	217.34%	-442.80%	-1.66	0.63	100.00%	-508.40%	-382.20%
BIIB	BIOGEN INC	$28.71B	7.30%	4.50%	5.97%	12.30%	0.61	2.68	75.70%	13.10%	15.74%
HUM	HUMANA INC	$22.25B	7.30%	2.60%	6.63%	7.00%	1.68	2.02	14.90%	1.00%	1.76%
LNTH	LANTHEUS HOLDINGS INC	$4.73B	14.80%	8.00%	13.60%	22.30%	1.03	2.67	62.20%	11.00%	17.19%
XRAY	DENTSPLY SIRONA INC	$2.48B	-47.70%	-15.00%	-18.39%	-20.60%	2.83	1.48	50.90%	-24.30%	-21.55%
BIO	BIO-RAD LABORATORIES INC	$7.15B	10.90%	7.60%	10.38%	10.90%	0.42	5.62	51.90%	29.40%	40.43%
STTK	SHATTUCK LABS INC	$253.12M	-73.80%	-66.00%	-57.79%	-212.60%	0.08	17.00	100.00%	-5,489.50%	-5,489.50%
DERM	JOURNEY MEDICAL CORP	$219.80M	-39.90%	-10.50%	-10.88%	-28.40%	2.29	1.42	70.20%	-14.60%	-8.33%
VRDN	VIRIDIAN THERAPEUTICS INC	$2.70B	-52.60%	-47.10%	-56.88%	-61.20%	0.15	11.28	100.00%	-426.60%	-423.02%
ORMP	ORAMED PHARMACEUTICALS INC	$127.37M	27.20%	25.60%	20.05%	36.60%	0.09	22.25	0.60%	2,192.60%	2,149.00%
WAY	WAYSTAR HOLDING CORP	$4.66B	3.30%	2.30%	4.48%	16.60%	0.49	1.41	68.30%	10.20%	22.68%
ATR	APTARGROUP INC	$9.12B	14.70%	8.00%	13.32%	20.50%	0.96	1.62	37.20%	10.40%	14.41%
UTHR	UNITED THERAPEUTICS CORP	$20.77B	18.80%	16.80%	24.85%	31.70%	0.12	6.40	88.60%	40.70%	54.04%
ASMB	ASSEMBLY BIOSCIENCES INC	$440.03M	-59.00%	-28.60%	-20.70%	-62.50%	0.31	4.44	N/A	N/A	N/A
SABS	SAB BIOTHERAPEUTICS INC	$184.71M	33.40%	25.30%	11.00%	32.60%	0.11	10.50	100.00%	16,338.30%	16,554.61%
INSP	INSPIRE MEDICAL SYSTEMS INC	$1.73B	21.10%	17.90%	8.12%	10.00%	0.16	6.08	85.40%	15.90%	7.22%
CGON	CG ONCOLOGY INC	$4.35B	-21.70%	-20.80%	-21.66%	-24.80%	0.06	22.79	27.50%	-6,968.00%	-6,967.99%
ICLR	ICON PLC	$6.77B	6.30%	3.60%	6.18%	18.50%	0.77	1.06	28.10%	7.40%	10.13%
CHE	CHEMED CORP	$6.70B	24.40%	16.60%	27.95%	64.00%	0.51	1.35	32.90%	11.00%	14.71%
ABT	ABBOTT LABORATORIES	$195.21B	28.10%	16.90%	12.42%	19.00%	0.64	1.70	55.90%	31.90%	19.72%
PFE	PFIZER INC	$155.62B	10.90%	4.70%	5.31%	8.30%	1.25	1.28	73.40%	15.70%	14.56%
BAX	BAXTER INTERNATIONAL INC	$10.67B	-13.80%	-4.60%	-1.90%	-2.10%	2.28	2.31	30.10%	-8.50%	-2.88%
BNTX	BIONTECH SE	$25.73B	-3.00%	-2.60%	-2.32%	-5.00%	0.16	7.12	82.50%	-18.10%	-14.07%
TKNO	ALPHA TEKNOVA INC	$106.52M	-23.50%	-16.20%	-17.39%	-14.80%	0.48	5.27	31.00%	-45.80%	-43.99%
GRAL	GRAIL INC	$3.86B	-17.20%	-14.60%	-21.60%	-81.80%	0.16	7.61	-47.50%	-286.40%	-384.26%
ARWR	ARROWHEAD PHARMACEUTICALS INC	$8.92B	36.10%	13.60%	24.97%	17.70%	1.83	3.38	100.00%	18.50%	28.77%
GKOS	GLAUKOS CORP	$6.12B	-11.40%	-8.90%	-8.98%	-14.80%	0.30	5.20	76.90%	-18.60%	-17.42%
GH	GUARDANT HEALTH INC	$13.50B	N/A	-29.30%	-37.91%	-23.20%	-4.60	3.50	63.80%	-44.20%	-43.68%
IBRX	IMMUNITYBIO INC	$5.93B	N/A	-86.70%	-48.87%	-21.30%	-1.99	5.77	99.60%	-422.30%	-273.40%
INMD	INMODE LTD	$917.43M	14.50%	12.90%	15.86%	25.30%	0.12	9.88	78.50%	25.30%	29.78%
ADMA	ADMA BIOLOGICS INC	$3.80B	54.00%	39.40%	32.05%	35.70%	0.32	7.13	54.70%	42.90%	33.60%
SCYX	SCYNEXIS INC	$31.89M	-54.30%	-37.40%	-58.43%	-52.10%	0.40	5.75	100.00%	-862.90%	-849.01%
LFCR	LIFECORE BIOMEDICAL INC	$268.26M	N/A	N/A	N/A	N/A	-18.83	2.80	N/A	N/A	N/A
MESO	MESOBLAST LTD	$2.16B	-19.00%	-14.10%	-11.56%	-103.10%	0.31	1.99	70.20%	-593.90%	-458.45%
SMTI	SANARA MEDTECH INC	$170.58M	-127.50%	-42.30%	-58.21%	-53.10%	10.56	1.80	92.30%	-36.80%	-30.69%
AGEN	AGENUS INC	$103.73M	N/A	-16.70%	-46.53%	346.20%	-1.88	0.47	98.90%	-33.10%	23.19%
GLUE	MONTE ROSA THERAPEUTICS INC	$1.20B	8.30%	5.10%	5.51%	9.80%	0.87	6.54	100.00%	11.50%	12.09%
DOCS	DOXIMITY INC	$4.54B	22.90%	19.60%	27.43%	33.30%	0.18	6.63	89.70%	37.50%	43.32%
ELV	ELEVANCE HEALTH INC	$76.09B	13.00%	4.70%	10.08%	13.10%	1.77	1.54	14.90%	2.80%	4.07%
INBX	INHIBRX BIOSCIENCES INC	$1.15B	-186.10%	-76.30%	-103.24%	-213.90%	3.82	4.49	100.00%	-11,077.60%	-10,433.79%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	610	+1.46%	+0.32%	-0.48%	-29.81%	203.20x	5.16x	-23.77%	-9.51%	-6.53%	+67.37%	Strong Buy
Diagnostics & Research	56	-0.40%	-4.39%	-12.07%	+6.08%	16.70x	3.97x	-4.44%	+6.36%	+11.82%	+22.58%	Buy
Drug Manufacturers - General	20	+0.36%	+2.68%	+8.12%	+28.89%	43.99x	7.33x	+100.80%	+12.44%	+21.08%	+4.47%	Buy
Drug Manufacturers - Specialty & Generic	75	+1.04%	-0.27%	+0.71%	-27.50%	-166.20x	1.75x	+9.97%	+2.28%	+5.20%	+42.63%	Buy
Healthcare Plans	10	-0.35%	+4.19%	-12.63%	-24.67%	19.38x	1.91x	+11.67%	+3.66%	+8.52%	+20.65%	Buy
Health Information Services	54	+0.76%	-3.56%	-18.69%	-91.47%	27.39x	3.20x	+8.66%	+4.39%	+6.53%	+66.23%	Buy
Medical Care Facilities	50	-0.09%	+5.82%	+12.69%	-30.49%	16.89x	5.91x	-68.69%	+7.69%	+15.92%	+10.21%	Buy
Medical Devices	139	+1.82%	-1.81%	-5.06%	-84.07%	21.83x	3.65x	+11.89%	+7.22%	+9.67%	+41.83%	Strong Buy
Medical Distribution	10	+0.90%	+0.77%	+10.03%	+52.80%	32.39x	277.72x	-98.61%	+3.54%	+23.66%	+2.69%	Buy
Medical Instruments & Supplies	57	+0.57%	-0.94%	-3.87%	-14.92%	171.28x	3.06x	+9.60%	+8.37%	+10.83%	+23.32%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Feb 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Pediatrix Medical Group (NYSE:MD)

Pediatrix Medical Group (NYSE:MD) is the #1 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pediatrix Medical Group (NYSE:MD) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: C.

Pediatrix Medical Group (NYSE:MD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Pediatrix Medical Group has seen its stock return 51.92% over the past year, overperforming other healthcare stocks by 105 percentage points.

Pediatrix Medical Group has an average 1 year price target of $21.33, a downside of -1.74% from Pediatrix Medical Group's current stock price of $21.71.

Pediatrix Medical Group stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Pediatrix Medical Group, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #2 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 30, which is 4 points higher than the healthcare sector average of 26. It passed 10 out of 33 due diligence checks and has average fundamentals. Bioventus has seen its stock lose -19.35% over the past year, overperforming other healthcare stocks by 33 percentage points.

Bioventus has an average 1 year price target of $13.00, an upside of 55.13% from Bioventus's current stock price of $8.38.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the #3 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ironwood Pharmaceuticals (NASDAQ:IRWD) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: C.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a Due Diligence Score of 40, which is 14 points higher than the healthcare sector average of 26. It passed 13 out of 33 due diligence checks and has average fundamentals. Ironwood Pharmaceuticals has seen its stock return 139% over the past year, overperforming other healthcare stocks by 192 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $6.50, an upside of 35.98% from Ironwood Pharmaceuticals's current stock price of $4.78.

Ironwood Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Ironwood Pharmaceuticals, 0% have issued a Strong Buy rating, 50% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 68 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 29.06%, which is 27 percentage points higher than the healthcare sector average of 2.26%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 9.1%, which is 7 percentage points higher than the healthcare sector average of 2.26%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.81%, which is 6 percentage points higher than the healthcare sector average of 2.26%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.81% in the last day, and down -0.2% over the last week. Polaryx Therapeutics was the among the top gainers in the healthcare sector, gaining 64.32% yesterday.

Polaryx shares are trading higher after the company announced it selected a contract research organization for SOTERIA to evaluate PLX-200, across four different LSDs.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 68 points higher than the healthcare sector average of 18. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -32.88% in the past year. It has overperformed other stocks in the healthcare sector by 20 percentage points.

2. Nutex Health (NASDAQ:NUTX)

Nutex Health (NASDAQ:NUTX) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Nutex Health has a valuation score of 57, which is 39 points higher than the healthcare sector average of 18. It passed 4 out of 7 valuation due diligence checks.

Nutex Health's stock has gained 53.58% in the past year. It has overperformed other stocks in the healthcare sector by 106 percentage points.

3. Organon & Co (NYSE:OGN)

Organon & Co (NYSE:OGN) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -52.97% in the past year. It has performed in line with other stocks in the healthcare sector.

Are healthcare stocks a good buy now?

57.82% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.3% over the next year.

6.59% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.93% of healthcare stocks are rated B (Buy), 46.95% are rated C (Hold), 25.03% are rated D (Sell), and 8.5% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 59.51x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Bioventus (NASDAQ:BVS)

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Embecta (NASDAQ:EMBC)

2. Nutex Health (NASDAQ:NUTX)

3. Organon & Co (NYSE:OGN)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Bioventus (NASDAQ:BVS)

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Embecta (NASDAQ:EMBC)

2. Nutex Health (NASDAQ:NUTX)

3. Organon & Co (NYSE:OGN)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.